Myanmar vs United States of America: Dealing with construction permits: Building quality control index
Myanmar
80
in 2019
United States of America
82.67
in 2019
Myanmar rank
50th
United States of America rank
49th
Dealing with construction permits: Building quality control index over time
- Myanmar
- United States of America
How they compare
United States of America currently reports 82.67 against 80 in Myanmar, a difference of 2.67.
Across all 6 years both countries report, United States of America has been ahead every year.
Myanmar ranks 50th and United States of America ranks 49th of 191 countries.
United States of America has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher dealing with construction permits: building quality control index, Myanmar or United States of America?
- United States of America, at 82.67 against 80 in Myanmar as of 2019.
- What is the difference in dealing with construction permits: building quality control index between Myanmar and United States of America?
- 2.67, with United States of America ahead.
- How many years of comparable data are there for Myanmar and United States of America?
- 6 years are reported by both, from 2014 to 2019.
- How do Myanmar and United States of America rank globally for dealing with construction permits: building quality control index?
- Myanmar ranks 50th and United States of America ranks 49th of 191 countries.
- Where does this data come from?
- The World Bank, published as Dealing with construction permits: Building quality control index (0-15) (DB16-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for the building quality control index benchmarks economies with respect to the regulatory best practice on the indicator. The score ranges from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB16-20 studies.